Large-scale testing (Phase 3)Study completedNCT00691262
What this trial is testing
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 166